Consensus report of the 2nd International Forum for Liver MRI.
about
Imaging of HCC-Current State of the ArtMagnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acidAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaThe role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewEvaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI.Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRIEffects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisationFeasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or CirrhosisDynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: emphasis on image quality and hepatocellular carcinoma detection.Liver lesion detection and characterization: role of diffusion-weighted imaging.Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis.Influence of the Magnetic Field Strength on Image Contrast in Gd-EOB-DTPA-enhanced MR Imaging: Comparison between 1.5T and 3.0TQuantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangiomaIntrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases.Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo.Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography.Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.Contrast-enhanced MR cholangiography with Gd-EOB-DTPA for preoperative biliary mapping: correlation with intraoperative cholangiography.Radial volumetric imaging breath-hold examination (VIBE) with k-space weighted image contrast (KWIC) for dynamic gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI of the liver: advantages over Cartesian VIBE in the arterial phase.Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease.Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CTDynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT
P2860
Q26768463-BD047AD6-1F17-4647-9F51-F9CF59EFD292Q26769602-58569B86-2CEA-4749-8F17-47538C4048ACQ26772334-51490967-C282-4BC1-9E7B-0E27027807DEQ26828543-CCA9EBBD-B27E-4644-B656-6BE41C6B3895Q30422395-66F7852C-160E-4630-A025-7A636F75B71DQ33784125-2F8C46B7-D5D2-43D7-B967-63B012E8549CQ34391776-59FDED73-FE3E-4825-A79E-8D480F37C88BQ34466458-A3EF2F4E-5CBD-4EA4-97A3-1D57C2C4DD66Q34681076-160DD56A-0559-4FED-B6F9-1E55B315516CQ35056708-7ED7D684-3B4F-433D-83F9-B72F71AD7374Q35207733-C532615F-E740-408C-8105-29AD15E814AAQ35720896-3ACB9DCE-BBA0-487C-83FA-D9009EB00325Q35775870-F92270EA-44D9-4C59-B5F2-6A55EAB646A4Q35909487-0A2CF6DA-C654-42ED-A91B-C3B5898F2CD2Q36103404-2AF35684-2ED0-47F9-B50A-F0A3FC3D38A1Q36201171-82679303-EFAB-4497-AD5F-55C64D06066CQ36218200-32A2C177-E6CE-4022-AB97-90FDC376FF21Q37924180-FB879E54-C1C4-439F-B06C-294A4B746DE3Q37950331-94F705A5-F314-4DCC-830D-3CB1258A4AA6Q38071993-776A9FCA-C907-4BB7-B986-5A481A0EB958Q38109869-0D4E5203-2531-4AC1-8A9D-4145211CB67CQ39180805-46366AC6-42DC-451F-BCBC-74F02ADCB671Q40706953-372F0FCE-5992-4F10-B05B-00E92E30857AQ42359392-0E30F993-9976-4EE3-B164-9A744383CCD9Q42371543-FA699603-3C64-46CF-B319-F130288E2ABEQ45100463-32795442-FEDA-4392-817B-6FC86791C8B4Q45796271-A3C404AE-C9C7-4B34-91D4-14120E8D99E7Q50154263-BA396291-3B05-4DF0-ADAC-8980C959D150Q51637668-6DBCC066-CE26-4812-B055-AF0077435850Q53058162-E4366C15-F10D-47E3-9289-4D878208DF9BQ53074951-2C93FCD3-2085-446B-B8B6-2EE81F697D3AQ53127886-670CAFC4-8EBA-4100-B0D7-925A2337BFDAQ53223315-90E6826D-9B1A-4BA7-899B-C2C8C56ADEBDQ53511595-575A40F6-6136-44F5-9603-6E59459A217CQ56741838-28148A37-9088-4B64-91D0-1C3FC458750BQ59115810-3D777BCA-BC34-414A-869A-2BB2989C182B
P2860
Consensus report of the 2nd International Forum for Liver MRI.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus report of the 2nd International Forum for Liver MRI.
@en
Consensus report of the 2nd International Forum for Liver MRI.
@nl
type
label
Consensus report of the 2nd International Forum for Liver MRI.
@en
Consensus report of the 2nd International Forum for Liver MRI.
@nl
prefLabel
Consensus report of the 2nd International Forum for Liver MRI.
@en
Consensus report of the 2nd International Forum for Liver MRI.
@nl
P2093
P2860
P1433
P1476
Consensus report of the 2nd International Forum for Liver MRI.
@en
P2093
Akihiro Tanimoto
Alexander Huppertz
Luigi Grazioli
Takamichi Murakami
P2860
P2888
P304
P356
10.1007/S00330-009-1624-Y
P407
P478
19 Suppl 5
P577
2009-10-01T00:00:00Z